Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.

BACKGROUND: Antidepressants exhibit a variety of pharmacological actions including inhibition of the serotonin and noradrenaline transporters. We wished to investigate whether genetic variation could be used to target or personalise treatment, in a comparison of selective serotonin reuptake inhibito...

Bibliografski detalji
Glavni autori:	Lewis, G, Mulligan, J, Wiles, N, Cowen, P, Craddock, N, Ikeda, M, Grozeva, D, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Peters, T
Format:	Journal article
Jezik:	English
Izdano:	2011

Slični predmeti

Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
od: Wiles, N, i dr.
Izdano: (2012)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
od: Crawford, A, i dr.
Izdano: (2014)

Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
od: Crawford, A, i dr.
Izdano: (2014)

GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
od: Thomas, L, i dr.
Izdano: (2008)

GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
od: O'Donovan Michael, i dr.
Izdano: (2008-05-01)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
od: Wiles, N, i dr.
Izdano: (2014)

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
od: Gartside, SE, i dr.
Izdano: (1992)

A role for 5-HT in the action of antidepressant drugs.
od: Cowen, P
Izdano: (1990)

5-HT RECEPTOR SENSITIVITY DURING ANTIDEPRESSANT DRUG-TREATMENT
od: Cowen, P
Izdano: (1993)

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
od: Glue, P, i dr.
Izdano: (1986)

Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines.
od: Nutt, D, i dr.
Izdano: (1987)

The effect of diazepam on indices of 5-HT function in man.
od: Nutt, D, i dr.
Izdano: (1986)

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
od: Cowen, P, i dr.
Izdano: (1987)

5-HT and depression: is the glass half-full?
od: Sharp, T, i dr.
Izdano: (2011)

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
od: Bould, H, i dr.
Izdano: (2012)

Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial
od: Bould, H, i dr.
Izdano: (2012)

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.
od: Rabiner, E, i dr.
Izdano: (2000)

Antidepressants; what's the beef?
od: Goodwin, G, i dr.
Izdano: (2019)

A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial
od: DJ Sharp, i dr.
Izdano: (2010-09-01)

Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment.
od: Sharpley, A, i dr.
Izdano: (1990)

Role of 5-HT3 Receptors in the Antidepressant Response
od: Connie Sanchez, i dr.
Izdano: (2011-04-01)

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
od: Taichi Ochi, i dr.
Izdano: (2019-12-01)

Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses.
od: Best, N, i dr.
Izdano: (1992)

Attacks on antidepressants: signs of deep-seated stigma?
od: Nutt, D, i dr.
Izdano: (2014)

Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate co-transmission
od: Sengupta, A, i dr.
Izdano: (2017)

Effect of valine on 5-HT neurotransmission and mood.
od: Cowen, P, i dr.
Izdano: (1996)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
od: Karolina Pytka, i dr.
Izdano: (2015-01-01)

Can we measure 5-HT release with PET?
od: Grasby, P, i dr.
Izdano: (2003)

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
od: Quérée, P, i dr.
Izdano: (2009)

ANTIDEPRESSANT EFFECTS OF HIPPOCAMPAL 5-HT7 RECEPTORS BLOCKADE IN RATS
od: Júlia Gonçalez, i dr.
Izdano: (2023-10-01)

Brain 5-HT neurotransmission during paroxetine treatment.
od: Sargent, P, i dr.
Izdano: (1998)

Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions
od: Alain M Gardier
Izdano: (2013-08-01)

Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis.
od: Gartside, SE, i dr.
Izdano: (1992)

Lack of effect of oestradiol implant on platelet imipramine and 5-HT2 receptor binding in menopausal subjects.
od: Best, N, i dr.
Izdano: (1989)

IN-VIVO EVIDENCE THAT D-FENFLURAMINE RELEASES 5-HT FROM NERVE-TERMINALS OF BOTH THE DORSAL AND MEDIAN RAPHE NUCLEI
od: Mcquade, R, i dr.
Izdano: (1995)

Augmentation strategies: 5-HT and beyond
od: Cowen, P
Izdano: (2002)

EFFECT OF AMINO-ACID LOADS ON HIPPOCAMPAL 5-HT RELEASE INVITRO EVOKED BY ELECTRICAL-STIMULATION OF THE DORSAL RAPHE NUCLEUS AND D-FENFLURAMINE ADMINISTRATION
od: Gartside, S, i dr.
Izdano: (1992)

Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo.
od: Gartside, SE, i dr.
Izdano: (1992)

Depression resistant to tricyclic antidepressants.
od: Cowen, P
Izdano: (1988)

Serotonin, depression and antidepressant action
od: Cowen, P
Izdano: (2013)